Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Peng Yin
Harvard Medical School, Department: Internal Medicine/medicine
Should you be removed from our database? Contact us at [email protected]. Read more below.
Ultivue, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Dr. Yin serves as a consultant to Ultivue. The company has licensed the DNA-PAINT technology and is focused on developing commercially available reagents that could be used to give a microscope the ability to easily perform multiplexed super-resolution imaging. In Dr. Yin’s role as consultant to the company, he advises them on the productization of the already invented and developed DNA-PAINT technology into robust reagents for the general markets. The research project aims to offer a new approach to biological imaging, new discoveries in breast cancer, and new open-access resources containing proteomic data at the sub-cellular level, for any cell in an entire centimeter sized histological tissue section. This project is made possible by technology innovations that combine the super-resolution imaging capabilities of multiplexed DNA-PAINT with automated image acquisition and “big data” management strategies, thus making improvements over current methods that emphasize either super-resolution or tissue-scale data.
The Molecular Atlas Project
Just as Google Maps revolutionized the way we view and interact with geography, the Molecular Atlas Project aims to revolutionize the way we view and interact with biological tissues. This combined wetware, hardware, and software approach to imaging is a proteome visualization pipeline for length scales ranging from the molecular to the macroscopic. Completion will enhance our understanding of the human body and its ailments with unprecedented detail, while laying a foundation for next generation therapeutics - try it yourself and explore the possibilities at www.molecular-atlas.net
Filed on April 15, 2016.
Tell us what you know about Peng Yin's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Peng Yin”
Name | Institution | Type | Company | Disclosed Value |
---|---|---|---|---|
Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | $0 - $4,999 |
Peng Yin | Harvard Medical School | Conflict of Interest | Ultivue, Inc. | $100,000 - $149,999 |
Peng Yin | Harvard Medical School | Conflict of Interest | Ultivue | Value cannot be readily determined |
Peng Yin | Harvard Medical School | Conflict of Interest | Ultivue, Inc. | $100,000 - $149,999 |
Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | Value cannot be readily determined |
Peng Yin | Harvard Medical School | Conflict of Interest | Ultivue, Inc. | Value cannot be readily determined |
Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | $100,000 - $149,999 |
Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | $100,000 - $149,999 |
Peng Yin | Harvard University | Conflict of Interest | Ultivue Inc. | $0 - $4,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.